Pfizer and its German partner BioNTech asked London's Court of Appeal on Thursday to overturn a ruling that their COVID-19 ...

The U.S. Food and Drug Administration has granted full approval for Moderna's COVID-19 vaccine, Spikevax, in children aged 6 ...

In an interview with The News & Observer, Dr. Barton Haynes discusses the future of HIV vaccine development after HHS ...

The US Centers for Disease Control and Prevention on Wednesday tallied the highest number of US measles cases since the ...

The U.S. Food and Drug Administration has granted full approval for Moderna's COVID-19 vaccine, Spikevax, in children aged 6 ...

Spikevax is now approved for all adults aged 65 years and older, and individuals aged 6 months through 64 years at increased risk for COVID-19 disease CAMBRIDGE, MA / ACCESS Newswire / July 10, 2025 / ...

Osivax has released phase 2a trial data confirming that its broad-spectrum flu vaccine candidate, OVX836, can be safely ...

Researchers from Tel Aviv University and the Israel Institute for Biological Research in Ness Ziona have used the platform ...

European Commission President Ursula von der Leyen survived a no-confidence vote in the European Parliament on Thursday, ...

In a significant legal challenge that could reshape the future of public health policy in the United States, a powerful ...

Kim Gab Jung (right), director general of the KDCA's Department of Disease Diagnosis and Analysis, on July 1 answers ...

The complaint, filed by a coalition of medical professional groups, also said candidates would not be allowed to join if they ...